Key result
Speckle-tracking echocardiography provides valuable insights into myocardial involvement and risk stratification in patients with acute COVID-19 and post-COVID syndrome.
Why the study?
Despite many publications on speckle-tracking echocardiography in COVID-19, questions remain unanswered regarding specific pathomechanisms, especially in post-COVID syndrome.
This review highlights the utility of speckle-tracking echocardiography for evaluating myocardial involvement and risk stratification in acute and post-COVID-19 patients.
Strain echocardiography may aid myocardial risk stratification in acute and post-COVID patients; leaves open pathomechanisms and needs prospective validation.
Speckle-tracking echocardiography (STE) has become an established, widely available diagnostic method in the past few years, making its value clear in cases of COVID-19 and the further course of the disease, including post-COVID syndrome. Since the beginning of the pandemic, many studies have been published on the use of STE in this condition, enabling, on the one hand, a better understanding of myocardial involvement in COVID-19 and, on the other, a better identification of risk to patients, although some questions remain unanswered in regard to specific pathomechanisms, especially in post-COVID patients. This review takes a closer look at current findings and potential future developments by summarising the extant data on the use of STE, with a focus on left and right ventricular longitudinal strain.
No takes yet. Share an insight, caveat, or question.
Kersten et al. (2023) conducted a review in Acute COVID-19 and Post-COVID Syndrome. Speckle-tracking echocardiography (STE) was evaluated. Speckle-tracking echocardiography provides valuable insights into myocardial involvement and risk stratification in patients with acute COVID-19 and post-COVID syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: